| Access Health - Fort Pierre | |
|
202 Island Dr Ste 1 Fort Pierre SD 57532-7303 | |
| (605) 223-2200 | |
| (605) 223-2228 |
| Full Name | Access Health - Fort Pierre |
|---|---|
| Speciality | Clinic/Center |
| Location | 202 Island Dr Ste 1, Fort Pierre, South Dakota |
| Authorized Official Name and Position | James Hardwick (CEO) |
| Authorized Official Contact | 6052232200 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Access Health - Fort Pierre 202 Island Dr Ste 1 Fort Pierre SD 57532-7303 Ph: (605) 223-2200 | Access Health - Fort Pierre 202 Island Dr Ste 1 Fort Pierre SD 57532-7303 Ph: (605) 223-2200 |
| NPI Number | 1487667077 |
|---|---|
| Provider Enumeration Date | 08/14/2006 |
| Last Update Date | 04/24/2023 |
| Medicare PECOS PAC ID | 3476447541 |
|---|---|
| Medicare Enrollment ID | O20061018000703 |
News Archive
New research in monkeys suggests that a diet high in the natural plant estrogens found in soy does not increase the risk of breast or uterine cancer in postmenopausal women.
Otsuka Pharmaceutical Co., Ltd. announced today that the European Medicines Agency (EMA) has accepted the submission of a marketing authorisation application (MAA) for the potential approval of tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD).
Alkermes, Inc. today announced preliminary results from a phase 2 clinical study of ALKS 33, one of Alkermes' proprietary candidates for the treatment of reward disorders and other central nervous system (CNS) disorders. The 12-week study was designed to assess the safety and efficacy of daily oral administration of three different dose levels of ALKS 33 compared to placebo in 400 alcohol dependent patients.
Tasmanian Devil Salem died at age seven but made a difference to her endangered species. Only 50 micrograms of her tissue was taken and processed by Australian genetic scientist Elizabeth Murchison, using new US technology, to produce the first devil genome sequence. As a result, the fight against devil facial tumor disease now has a draft DNA reference map. This was presented at a genetic conference in Hobart yesterday.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487667077 | NPI | - | NPPES |
| 4993549 | Other | SD | BCBS |
| 5350280 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
New research in monkeys suggests that a diet high in the natural plant estrogens found in soy does not increase the risk of breast or uterine cancer in postmenopausal women.
Otsuka Pharmaceutical Co., Ltd. announced today that the European Medicines Agency (EMA) has accepted the submission of a marketing authorisation application (MAA) for the potential approval of tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD).
Alkermes, Inc. today announced preliminary results from a phase 2 clinical study of ALKS 33, one of Alkermes' proprietary candidates for the treatment of reward disorders and other central nervous system (CNS) disorders. The 12-week study was designed to assess the safety and efficacy of daily oral administration of three different dose levels of ALKS 33 compared to placebo in 400 alcohol dependent patients.
Tasmanian Devil Salem died at age seven but made a difference to her endangered species. Only 50 micrograms of her tissue was taken and processed by Australian genetic scientist Elizabeth Murchison, using new US technology, to produce the first devil genome sequence. As a result, the fight against devil facial tumor disease now has a draft DNA reference map. This was presented at a genetic conference in Hobart yesterday.
› Verified 6 days ago
Sc Clinical Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 213 E Hustan Ave, Fort Pierre, SD 57532 Phone: 605-609-7873 Fax: 605-223-9201 |